IXICO (LON:IXI) Issues Quarterly Earnings Results

IXICO (LON:IXI) posted its quarterly earnings results on Tuesday. The company reported GBX (1.21) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 395 million for the quarter. IXICO had a negative return on equity of 13.74% and a negative net margin of 25.27%.

IXICO Trading Up 25.4%

Shares of IXI opened at GBX 8.25 on Tuesday. The company has a current ratio of 3.03, a quick ratio of 4.90 and a debt-to-equity ratio of 1.53. The firm’s 50-day moving average is GBX 7.34 and its two-hundred day moving average is GBX 9.48. IXICO has a twelve month low of GBX 6.26 and a twelve month high of GBX 15. The firm has a market capitalization of £17.99 million, a P/E ratio of -4.46, a PEG ratio of -0.38 and a beta of 0.07.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.